Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model.

Abstract:

:Heterotopic ossification (HO) involves formation of endochondral bone at non-skeletal sites, is prevalent in severely wounded service members, and causes significant complications and delayed rehabilitation. As common prophylactic treatments such as anti-inflammatory drugs and irradiation cannot be used after multi-system combat trauma, there is an urgent need for new remedies. Previously, we showed that the retinoic acid receptor γ agonist Palovarotene inhibited subcutaneous and intramuscular HO in mice, but those models do not mimic complex combat injury. Thus, we tested Palovarotene in our validated rat trauma-induced HO model that involves blast-related limb injury, femoral fracture, quadriceps crush injury, amputation and infection with methicillin-resistant Staphylococcus aureus from combat wound infections. Palovarotene was given orally for 14days at 1mg/kg/day starting on post-operative day (POD) 1 or POD-5, and HO amount, wound dehiscence and related processes were monitored for up to 84days post injury. Compared to vehicle-control animals, Palovarotene significantly decreased HO by 50 to 60% regardless of when the treatment started and if infection was present. Histological analyses showed that Palovarotene reduced ectopic chondrogenesis, osteogenesis and angiogenesis forming at the injury site over time, while fibrotic tissue was often present in place of ectopic bone. Custom gene array data verified that while expression of key chondrogenic and osteogenic genes was decreased within soft tissues of residual limb in Palovarotene-treated rats, expression of cartilage catabolic genes was increased, including matrix metalloproteinase-9. Importantly, Palovarotene seemed to exert moderate inhibitory effects on wound healing, raising potential safety concerns related to dosing and timing. Our data show for the first time that Palovarotene significantly inhibits HO triggered by blast injury and associated complications, strongly indicating that it may prevent HO in patients at high risk such as those sustaining combat injuries and other forms of blast trauma.

journal_name

Bone

journal_title

Bone

authors

Pavey GJ,Qureshi AT,Tomasino AM,Honnold CL,Bishop DK,Agarwal S,Loder S,Levi B,Pacifici M,Iwamoto M,Potter BK,Davis TA,Forsberg JA

doi

10.1016/j.bone.2016.06.014

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

159-67

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(16)30176-4

journal_volume

90

pub_type

杂志文章

相关文献

BONE文献大全
  • Crosstalk between Activin A and Shh signaling contributes to the proliferation and differentiation of antler chondrocytes.

    abstract::Chondrocyte proliferation and differentiation are crucial for endochondral ossification and strictly regulated by numerous signaling molecules and transcription factors, but the hierarchical regulatory network remains to be deciphered. The present study emphasized the interplay of Activin A, Foxa, Notch and Shh signal...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.03.036

    authors: Ma L,Duan CC,Yang ZQ,Ding JL,Liu S,Yue ZP,Guo B

    更新日期:2019-06-01 00:00:00

  • Teriparatide attenuates scarring around murine cranial bone allograft via modulation of angiogenesis.

    abstract::Nearly all bone fractures in humans can deteriorate into a non-union fracture, often due to formation of fibrotic tissue. Cranial allogeneic bone grafts present a striking example: although seemingly attractive for craniofacial reconstructions, they often fail due to fibrosis at the host-graft junction, which physical...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.01.020

    authors: Cohn Yakubovich D,Eliav U,Yalon E,Schary Y,Sheyn D,Cook-Wiens G,Sun S,McKenna CE,Lev S,Binshtok AM,Pelled G,Navon G,Gazit D,Gazit Z

    更新日期:2017-04-01 00:00:00

  • Does estrogen stimulate osteoblast function in postmenopausal women?

    abstract::How estrogen therapy influences bone metabolism in postmenopausal women has previously been studied using several approaches, including bone densitometry, measurement of biochemical markers of bone turnover, and histomorphometry. Taken together, these investigations suggest that conventional doses of estrogen protect ...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/s8756-3282(98)00156-2

    authors: Tobias JH,Compston JE

    更新日期:1999-02-01 00:00:00

  • Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement.

    abstract:INTRODUCTION:The RANKL-OPG axis is a key regulator of osteoclastogenesis and bone turnover activity. Its contribution to bone resorption under altered mechanical states, however, has not been fully elucidated. Here we examined the role of OPG in regulating mechanically induced bone modeling in a rat model of orthodonti...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2007.04.194

    authors: Dunn MD,Park CH,Kostenuik PJ,Kapila S,Giannobile WV

    更新日期:2007-09-01 00:00:00

  • Short-term activation of liver X receptors inhibits osteoblasts but long-term activation does not have an impact on murine bone in vivo.

    abstract::Liver X receptors (LXRs) are nuclear receptors that play a crucial role in the transcriptional control of lipid metabolism. Pharmacological LXR activation is an attractive concept for the treatment of atherosclerosis. Genetic LXR deficiency in mice has been shown to have an effect on bone turnover and structure and LX...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.08.018

    authors: Prawitt J,Beil FT,Marshall RP,Bartelt A,Ruether W,Heeren J,Amling M,Staels B,Niemeier A

    更新日期:2011-02-01 00:00:00

  • Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice.

    abstract::Ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) hydrolyse nucleotide triphosphates to the corresponding nucleotide monophosphates and the mineralisation inhibitor, pyrophosphate (PPi). This study examined the role of NPP1 in osteocytes, osteoclasts and cortical bone, using a mouse model lacking NPP1 (Enpp1(-...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.09.016

    authors: Hajjawi MO,MacRae VE,Huesa C,Boyde A,Millán JL,Arnett TR,Orriss IR

    更新日期:2014-12-01 00:00:00

  • Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

    abstract:INTRODUCTION:While the anti-resorptive effects of the bisphosphonates (BPs) are well documented, many questions remain about their mechanisms of action, particularly following long-term use. This study evaluated the effects of alendronate (Ale) treatment on TGF-β1 signaling in mesenchymal stem cells (MSCs) and osteocyt...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.10.017

    authors: Jia J,Yao W,Amugongo S,Shahnazari M,Dai W,Lay YA,Olvera D,Zimmermann EA,Ritchie RO,Li CS,Alliston T,Lane NE

    更新日期:2013-01-01 00:00:00

  • Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom.

    abstract::This cohort study of postmenopausal women in the United Kingdom aged ≥50years determined the incremental cost of health care and clinical outcomes in the 12months following incident, selected fractures (non-vertebral non-hip [NVNHF], vertebral [VF] and multiple [MF]). Incremental costs and outcomes of the fracture coh...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.05.020

    authors: Gutiérrez L,Roskell N,Castellsague J,Beard S,Rycroft C,Abeysinghe S,Shannon P,Gitlin M,Robbins S

    更新日期:2012-09-01 00:00:00

  • MSTN is a key mediator for low-intensity pulsed ultrasound preventing bone loss in hindlimb-suspended rats.

    abstract::Low-intensity pulsed ultrasound (LIPUS) has been used to accelerate bone fracture healing. However, the issue whether LIPUS is effective in preventing osteoporosis has not been clarified, and if so, what possible mechanisms might be responsible. Myostatin (MSTN) is a negative regulator of muscle growth, and its absenc...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115610

    authors: Tang L,An S,Zhang Z,Fan X,Guo J,Sun L,Ta D

    更新日期:2021-02-01 00:00:00

  • Novel therapeutic interventions for pseudoachondroplasia.

    abstract::Pseudoachondroplasia (PSACH), a severe short-limbed dwarfing condition, is associated with life-long joint pain and early onset osteoarthritis. PSACH is caused by mutations in cartilage oligomeric matrix protein (COMP), a pentameric matricellular protein expressed primarily in cartilage and other musculoskeletal tissu...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2017.03.045

    authors: Posey KL,Hecht JT

    更新日期:2017-09-01 00:00:00

  • Exposure to antiretroviral agents during pregnancy does not alter bone status in infants.

    abstract::The use of combined antiretroviral agents during pregnancy is important to prevent mother-to-child transmission of human immunodeficiency virus (HIV). Antiretroviral treatment (ARV) is associated with reduced bone mass and altered bone metabolism in HIV-infected patients. There are no data regarding the effect of ARV ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.10.030

    authors: Mora S,Giacomet V,Viganò A,Cafarelli L,Stucchi S,Pivetti V,Manfredini V,Puzzovio M,Zuccotti G

    更新日期:2012-01-01 00:00:00

  • Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.

    abstract::If muscle force is a primary source for triggering bone adaptation, with disuse and reloading, bone changes should follow muscle changes. We examined the timing and magnitude of changes in muscle cross-sectional area (MCSA) and bone architecture in response to muscle inactivity following botulinum toxin (BTX) injectio...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.10.016

    authors: Manske SL,Boyd SK,Zernicke RF

    更新日期:2010-01-01 00:00:00

  • 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes.

    abstract::Active vitamin D is a major therapeutic agent for bone disease. Although some studies have reported that vitamin D ameliorates bone disease related to diabetes, the mechanism remains unclear. Our study investigated the effect of the vitamin D receptor activator 22-oxacalcitriol (OCT) on bone disease in a rat model of ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2015.01.014

    authors: Goto S,Fujii H,Kono K,Nakai K,Awata R,Yonekura Y,Hirata M,Shinohara M,Nishi S,Fukagawa M

    更新日期:2015-05-01 00:00:00

  • Whole body vibration improves osseointegration by up-regulating osteoblastic activity but down-regulating osteoblast-mediated osteoclastogenesis via ERK1/2 pathway.

    abstract::Due to the reduction in bone mass and deterioration in bone microarchitecture, osteoporosis is an important risk factor for impairing implant osseointegration. Recently, low-magnitude, high-frequency (LMHF) vibration (LM: <1×g; HF: 20-90Hz) has been shown to exhibit anabolic, but anti-resorptive effects on skeletal ho...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.09.026

    authors: Zhou Y,Guan X,Liu T,Wang X,Yu M,Yang G,Wang H

    更新日期:2015-02-01 00:00:00

  • Modulation of bone resorption by glycosaminoglycans: effects of parathyroid hormone and interleukin-1.

    abstract::Regulation of calcium release from mouse calvariae by glycosaminoglycans and known modulators of bone resorption has been examined. Anticoagulant and nonanticoagulant fragments of heparin were combined with parathyroid hormone (PTH) and interleukin-1, beta (IL1), and calcium release from radiolabeled bone was determin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(88)90018-x

    authors: Cochran DL,Abernathy CK

    更新日期:1988-01-01 00:00:00

  • Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation.

    abstract::Osteoporosis is the consequence of altered bone metabolism resulting in the systemic reduction of bone strength and increased risk of fragility fractures. MicroRNAs (miRNAs) regulate gene expression on a post-transcriptional level and are known to take part in the control of bone formation and bone resorption. In addi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2015.05.027

    authors: Weilner S,Skalicky S,Salzer B,Keider V,Wagner M,Hildner F,Gabriel C,Dovjak P,Pietschmann P,Grillari-Voglauer R,Grillari J,Hackl M

    更新日期:2015-10-01 00:00:00

  • Effect of ED-71 on modeling of bone in distraction osteogenesis.

    abstract::We investigated the effect of 2-beta-(3-hydroxypropoxy)-1alpha,25-dihydroxyvitamin D3 (ED-71) on the modeling of bone in distraction osteogenesis. The tibiae of 30 rabbits were lengthened by 10 mm in 10 days. Following osteotomy, ED-71 (0.05 microg/kg) was administered subcutaneously twice a week to the ED-71 group un...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(98)00179-3

    authors: Yamane K,Okano T,Kishimoto H,Hagino H

    更新日期:1999-03-01 00:00:00

  • Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.

    abstract::Interleukin-1 (IL-1) has been shown to promote osteoclast (OC) differentiation, in addition to acting as a survival factor for mature osteoclasts. In this study, we investigate the expression of IL-1 during human osteoclast formation, taking advantage of a recently reported in vitro culture system that generates human...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(99)00176-3

    authors: Haynes DR,Atkins GJ,Loric M,Crotti TN,Geary SM,Findlay DM

    更新日期:1999-09-01 00:00:00

  • Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts.

    abstract::Recent studies have indicated a critical role for vascular endothelial growth factor (VEGF) during the process of endochondral ossification, in particular in coupling cartilage resorption with bone formation. Therefore, we studied the chemoattractive and proliferative properties of human VEGF-A on primary human osteob...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00690-1

    authors: Mayr-Wohlfart U,Waltenberger J,Hausser H,Kessler S,Günther KP,Dehio C,Puhl W,Brenner RE

    更新日期:2002-03-01 00:00:00

  • Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.

    abstract::Bone loss represents a major unsolved problem in rheumatoid arthritis (RA). The skeletal complications of RA consist of focal bone erosions and periarticular osteoporosis at sites of active inflammation, and generalized bone loss with reduced bone mass. New evidence indicates that osteoclasts are key mediators of all ...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/s8756-3282(01)00682-2

    authors: Romas E,Gillespie MT,Martin TJ

    更新日期:2002-02-01 00:00:00

  • Mechanical vibration inhibits osteoclast formation by reducing DC-STAMP receptor expression in osteoclast precursor cells.

    abstract::It is well known that physical inactivity leads to loss of muscle mass, but it also causes bone loss. Mechanistically, osteoclastogenesis and bone resorption have recently been shown to be regulated by vibration. However, the underlying mechanism behind the inhibition of osteoclast formation is yet unknown. Therefore,...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.08.020

    authors: Kulkarni RN,Voglewede PA,Liu D

    更新日期:2013-12-01 00:00:00

  • Expression of amelogenin in odontoblasts.

    abstract::Amelogenin is the major enamel protein produced by ameloblasts. Its expression has been shown to be down-regulated in ameloblasts of vitamin-D-deficient (-D) rats. The potential expression and localization of amelogenin in odontoblasts and its regulation by vitamin D were investigated in this study. RT-PCR and semi-qu...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00978-x

    authors: Papagerakis P,MacDougall M,Hotton D,Bailleul-Forestier I,Oboeuf M,Berdal A

    更新日期:2003-03-01 00:00:00

  • Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

    abstract::One year of treatment with bisphosphonates at 5x the dose used for post-menopausal osteoporosis significantly increases failure load and microdamage, and decreases toughness at multiple skeletal sites in intact female beagles. The goal of this study was to determine if similar changes occur with doses equivalent to th...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2006.04.028

    authors: Allen MR,Iwata K,Phipps R,Burr DB

    更新日期:2006-10-01 00:00:00

  • Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.

    abstract::Bisphosphonates are widely used to treat children with osteogenesis imperfecta (OI), a bone fragility disorder that is most often caused by mutations in COL1A1 or COL1A2. However, it is unclear whether this treatment decreases the risk of developing scoliosis. We retrospectively evaluated spine radiographs and charts ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.02.018

    authors: Sato A,Ouellet J,Muneta T,Glorieux FH,Rauch F

    更新日期:2016-05-01 00:00:00

  • Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment.

    abstract::A stabilized tibia fracture model was used in young (8-week old) and aged (1-year old) mice to define the relative bone regenerative potential and the relative responsiveness of the periosteal progenitor population with aging and PTH 1-34 (PTH) systemic therapy. Bone regeneration was assessed through gene expressions,...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.02.002

    authors: Yukata K,Xie C,Li TF,Takahata M,Hoak D,Kondabolu S,Zhang X,Awad HA,Schwarz EM,Beck CA,Jonason JH,O'Keefe RJ

    更新日期:2014-05-01 00:00:00

  • Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.

    abstract::Mutations in the GALNT3 gene result in familial tumoral calcinosis, characterized by persistent hyperphosphatemia and ectopic calcific masses in soft tissues. Since calcific masses often recur after surgical removal, a more permanent solution to the problem is required. Nicotinamide is reported to lower serum phosphat...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.06.036

    authors: Reilly AM,Gray AK,Moe SM,Ichikawa S

    更新日期:2014-10-01 00:00:00

  • In the ovariectomized rat, tamoxifen conserves bone similarly in parathyroid-intact and parathyroidectomized animals.

    abstract::To examine the ability of tamoxifen (TAM) to conserve bone in the estrogen-deficient ovariectomized (OVX) rat in the presence and absence of parathyroid hormone (PTH) six groups of rats with 45Ca-labeled bones were studied for 12 weeks. Rats were OVX, parathyroidectomized (PTX), or given sham operations and treated wi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(94)90273-9

    authors: Goulding A,Gold E

    更新日期:1994-09-01 00:00:00

  • Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.

    abstract::Biochemical bone turnover markers (BTMs) provide important information on the diagnosis, therapy and monitoring of metabolic bone diseases including osteoporosis. One goal of antiresorptive therapy in women is to decrease biochemical BTMs to the lower half of reference intervals for healthy pre-menopausal counterparts...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.07.017

    authors: Ardawi MS,Maimani AA,Bahksh TA,Rouzi AA,Qari MH,Raddadi RM

    更新日期:2010-10-01 00:00:00

  • Increased femoral neck cancellous bone and connectivity in coxarthrosis (hip osteoarthritis).

    abstract::Patients with coxarthrosis (cOA) have a reduced incidence of intracapsular femoral neck fracture, suggesting that cOA offers protection. The distribution of bone in the femoral neck was compared in cases of coxarthrosis and postmortem controls to assess the possibility that disease-associated changes might contribute ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00920-1

    authors: Jordan GR,Loveridge N,Bell KL,Power J,Dickson GR,Vedi S,Rushton N,Clarke MT,Reeve J

    更新日期:2003-01-01 00:00:00

  • The 24-hour serum profiles of bone markers in healthy older men and women.

    abstract::The process of bone turnover displays variations over 24 h, with C-terminal cross-linked telopeptide of type 1 collagen (CTX) and osteocalcin exhibiting a nadir in the afternoon and a peak in the night. In contrast, N-terminal propeptide of type 1 procollagen (P1NP) did not display an apparent 24-hour rhythm. Other em...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.10.002

    authors: van der Spoel E,Oei N,Cachucho R,Roelfsema F,Berbée JFP,Blauw GJ,Pijl H,Appelman-Dijkstra NM,van Heemst D

    更新日期:2019-03-01 00:00:00